Atopic Dermatitis - The Dermatology Digest

AD News: Roflumilast Cream 0.05% Now Available in Pharmacies Across the US

October 30, 2025

AD Pipeline Update: Concerto Biosciences’ ENS-002 Shows Safety and Efficacy in Phase 1b Trial

October 28, 2025

New Phase 3b Data Reinforce the Safety and Efficacy Profile of Ruxolitinib Cream in Moderate AD

October 27, 2025

Precision Medicine in AD: Castle Biosciences’ Pipeline AD Test Aims to Change the Way Your Patients Are Treated

October 25, 2025

Fall Clinical 2025 News: Roflumilast Cream Improves Sleep in AD Patients and Their Family Members

October 24, 2025

‘One Small Step Closer to an AD Cure’: What Eight-week Maintenance Dosing With Lebrikizumab Means for Eczema Patients and Providers

October 24, 2025

Advertisement

Advertisement

Latest Issue

Latest Supplements

Upcoming Conferences

Advertisement

Advertisement

Digital Edition Archive